Hosted on MSN29d
Eli Lily cuts 2024 revenue guidance by $400M, shares sink 8%Eli Lilly saw its shares crash in early trade on Tuesday as the ... for the year leading to an around 8% dip in its shares. The stock has gone down over 22% in the past six months.
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Eli Lilly exceeded analyst forecasts for both sales and earnings in Q4 2024. As has been true for a while, sales of GLP-1 drugs Mounjaro and Zepbound drove both sales and earnings growth.
Eli Lilly (LLY) stock is higher Thursday after the pharmaceutical company beat profit expectations and matched revenue forecasts for its fourth quarter and issued a better-than-expected outlook ...
Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of around $720 billion. For a while, it looked like it might be on track to be the first ...
February 11, 2025, 06:09 AM ET, BY Christie, Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...
February 06, 2025, 11:21 PM ET, BY Rick O., Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...
Eli Lilly (NYSE: LLY) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in this morning's Q4 earnings report. Heading into the report, analysts ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results